Skip to content
DataLookout
Menu

NCT03607552

Non-contrast DWI for Supplemental Screening

StatusActive, Not Recruiting
PhaseNot specified
Primary completion (estimated)

At risk: Primary completion moved at least 9 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 18 versions: 10 with changes below, 8 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion pushed from Sep 2026 to Jul 2027 Show 4 more changesShow less
    • Eligibility criteria expanded, about 5 words
    • Study description expanded, about 6 words
    • Site details revised at 1 of 2 sites
    • Publications: details revised at 3 of 3 entries
  2. Notable Primary completion date: Sep 2025 to Sep 2026
    • Study completion date: Jul 2028 to Jul 2029
    v16
  3. Notable Primary completion date: Sep 2024 to Sep 2025
    • Trial status: Enrolling by Invitation to Active, Not Recruiting
    • Enrollment target: estimated 375 to confirmed 269
    v12
  4. Notable Primary completion date: Jul 2023 to Sep 2024v11
  5. Minor Enrollment target: 275 to 375v8
Show 4 earlier versionsHide 4 earlier versions
  1. Minor Study sites: 1 to 2v6
  2. Minor Collaborators expanded, about 4 wordsv4
  3. Notable Trial status: Active, Not Recruiting to Enrolling by Invitationv3
  4. Minor Trial status: Enrolling by Invitation to Active, Not Recruitingv2
  1. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Diffusion sensitization (b value)
Timeframe: 2.5 years
Reader Interpretation strategy
Timeframe: 3.5 years
Specificity
Timeframe: 4.5 years
Sensitivity
Timeframe: 4.5 years

Arms and interventions

Phase 1: Pilot Study Phase

Optimize DWI sequences to maximize spatial resolution, reduce distortion, and increase lesion contrast.

Phase 2: Development Phase

Develop interpretation tools to optimize diagnostic performance for detecting cx on DWI.

Phase 3: Reader Performance Phase

Test the performance of the optimized DWI approach for detecting clinically and mammographically-occult cancer in women with dense breasts.

Devices: Non-contrast DWI, Non-contrast MRI

Sites

2 sites in 1 country